97cd6394 eb96 4002 be63 a881ef16184c

Cognition Therapeutics Inc.

CogRx is a clinical-stage pharmaceutical company developing novel drugs that work through a completely new mechanism to treat or prevent Alzheimer's disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded August 2007
  • Employees 8
  • Incorporation Type C-corp
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.